BRI3 Activators
BRI3 Activators comprise a spectrum of chemical compounds that indirectly promote the functional activity of BRI3 through various intracellular signaling cascades. Forskolin, by raising cAMP levels, and IBMX, by preventing cAMP breakdown, can both enhance BRI3 activity through a PKA-dependent mechanism, potentially influencing BRI3's cellular functions. In a similar fashion, Rolipram acts to elevate cAMP specifically via PDE4 inhibition, which could also engage BRI3 in PKA-mediated signaling. Epigallocatechin gallate, with its ability to inhibit a range of kinases, may amplify BRI3's signaling by attenuating competitive pathways, thereby indirectly potentiating BRI3's role. Thapsigargin and PMA stimulate calcium and PKC pathways, respectively, and their activation could reverberate through to BRI3's function by modulating related signaling networks.
Further, BRI3's activity could be influenced by modulators of the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways. LY294002 and Wortmannin, both PI3K inhibitors, could indirectly activate BRI3 by disrupting the PI3K/AKT signaling axis, potentially leading to an enhancement of BRI3-related signaling processes. U0126 and SB203580, targeting MEK and p38 MAPK respectively, could skew cellular signaling dynamics in favor of pathways involving BRI3. Lastly, Staurosporine, despite its broad action as a kinase inhibitor, may preferentially affect certain kinases that regulate BRI3 activity.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate and activate downstream proteins. BRI3, being involved in immune signaling, could be functionally enhanced due to PKA-mediated phosphorylation events in the signaling cascade where BRI3 plays a role. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC plays a pivotal role in several signal transduction pathways and could enhance the activity of BRI3 by phosphorylating components of the signaling pathway that BRI3 is involved in, thus leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. Calcium signaling is crucial for various cellular processes, including those in which BRI3 may be involved. The influx of calcium can activate calcineurin and other calcium-dependent protein kinases that could enhance the functional activity of BRI3 by modifying its interaction partners or its localization within the cell. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that acts as an agonist of beta-adrenergic receptors, leading to increased cAMP levels and activation of PKA. This can result in the phosphorylation of proteins in pathways associated with BRI3, potentially enhancing its functional activity. | ||||||
Spermine NONOate | 136587-13-8 | sc-202816 sc-202816A | 5 mg 25 mg | $53.00 $196.00 | 5 | |
Spermine NONOate releases nitric oxide (NO), a signaling molecule that often functions as a second messenger. NO can activate guanylyl cyclase, increasing cyclic GMP levels and activating protein kinase G (PKG). PKG phosphorylation of proteins in pathways where BRI3 is involved could lead to an enhancement of BRI3's functional activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs) like JNK. Activation of JNK can modify the activity of transcription factors and other proteins that may influence the signaling pathways of BRI3, potentially enhancing its activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can phosphorylate target proteins within the signaling pathways that include BRI3, potentially enhancing the functional activity of BRI3. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, similar to ionomycin. The rise in calcium can activate calcium-dependent signaling pathways, possibly leading to the activation of BRI3 through downstream effects of these pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump inhibitor, which leads to increased cytosolic calcium levels. Elevated calcium can activate signaling cascades that involve calmodulin-dependent kinases or calcineurin, which may indirectly enhance the activity of BRI3 through their downstream effects. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinases (PI3K) inhibitor, which can alter signaling pathways by preventing the production of PIP3 and activation of AKT. This alteration could lead to compensatory signaling through other pathways, potentially enhancing the activity of BRI3 if it is involved in these compensatory pathways. | ||||||